MohdMinhajuddinMohd Minhajuddin39.74515960000000-104.840628000000007529Minhajuddin, Mohd303/724-8232Assoc Professor-Researchprns:coAuthorOfcoauthor ofprns:emailEncryptedemail addressFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:address2address line 2vivo:address3address line 3vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsvivo:phoneNumberphonePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 901963MichaelVerneris/eEDZ7y5tWTHPhg4fnnekVFGSoYfD0+wHFBWvvLDHw==Michael Richard Verneris39.74403510000000-104.8360594000000011838Verneris, MichaelProfessor5Other Faculty1Professor3Asst Professor2Assoc Professor15843586Minhajuddin M, Fazal F, Bijli KM, Amin MR, Rahman AJournal of immunology (Baltimore, Md. : 1950)Minhajuddin M, Fazal F, Bijli KM, Amin MR, Rahman A. Inhibition of mammalian target of rapamycin potentiates thrombin-induced intercellular adhesion molecule-1 expression by accelerating and stabilizing NF-kappa B activation in endothelial cells. J Immunol. 2005 May 01; 174(9):5823-9.J Immunol2005-05-01T00:00:002005Inhibition of mammalian target of rapamycin potentiates thrombin-induced intercellular adhesion molecule-1 expression by accelerating and stabilizing NF-kappa B activation in endothelial cells.17158457Fazal F, Minhajuddin M, Bijli KM, McGrath JL, Rahman AThe Journal of biological chemistryFazal F, Minhajuddin M, Bijli KM, McGrath JL, Rahman A. Evidence for actin cytoskeleton-dependent and -independent pathways for RelA/p65 nuclear translocation in endothelial cells. J Biol Chem. 2007 Feb 09; 282(6):3940-50.J Biol Chem2006-12-08T00:00:002006Evidence for actin cytoskeleton-dependent and -independent pathways for RelA/p65 nuclear translocation in endothelial cells.19074768Minhajuddin M, Bijli KM, Fazal F, Sassano A, Nakayama KI, Hay N, Platanias LC, Rahman AThe Journal of biological chemistryMinhajuddin M, Bijli KM, Fazal F, Sassano A, Nakayama KI, Hay N, Platanias LC, Rahman A. Protein kinase C-delta and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells. J Biol Chem. 2009 Feb 13; 284(7):4052-61.J Biol Chem2008-12-13T00:00:002008Protein kinase C-delta and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells.AmandaWintersAmanda Catherine Winters39.74403510000000-104.8360594000000013003Winters, AmandaAsst Professor19483084Fazal F, Bijli KM, Minhajuddin M, Rein T, Finkelstein JN, Rahman AThe Journal of biological chemistryFazal F, Bijli KM, Minhajuddin M, Rein T, Finkelstein JN, Rahman A. Essential role of cofilin-1 in regulating thrombin-induced RelA/p65 nuclear translocation and intercellular adhesion molecule 1 (ICAM-1) expression in endothelial cells. J Biol Chem. 2009 Jul 31; 284(31):21047-56.J Biol Chem2009-05-29T00:00:002009Essential role of cofilin-1 in regulating thrombin-induced RelA/p65 nuclear translocation and intercellular adhesion molecule 1 (ICAM-1) expression in endothelial cells.15246972Rahman A, Anwar KN, Minhajuddin M, Bijli KM, Javaid K, True AL, Malik ABAmerican journal of physiology. Lung cellular and molecular physiologyRahman A, Anwar KN, Minhajuddin M, Bijli KM, Javaid K, True AL, Malik AB. cAMP targeting of p38 MAP kinase inhibits thrombin-induced NF-kappaB activation and ICAM-1 expression in endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2004 Nov; 287(5):L1017-24.Am J Physiol Lung Cell Mol Physiol2004-07-09T00:00:002004cAMP targeting of p38 MAP kinase inhibits thrombin-induced NF-kappaB activation and ICAM-1 expression in endothelial cells.17012367Bijli KM, Minhajuddin M, Fazal F, O'Reilly MA, Platanias LC, Rahman AAmerican journal of physiology. Lung cellular and molecular physiologyBijli KM, Minhajuddin M, Fazal F, O'Reilly MA, Platanias LC, Rahman A. c-Src interacts with and phosphorylates RelA/p65 to promote thrombin-induced ICAM-1 expression in endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2007 Feb; 292(2):L396-404.Am J Physiol Lung Cell Mol Physiol2006-09-29T00:00:002006c-Src interacts with and phosphorylates RelA/p65 to promote thrombin-induced ICAM-1 expression in endothelial cells.18362147Bijli KM, Fazal F, Minhajuddin M, Rahman AThe Journal of biological chemistryBijli KM, Fazal F, Minhajuddin M, Rahman A. Activation of Syk by protein kinase C-delta regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via tyrosine phosphorylation of RelA/p65. J Biol Chem. 2008 May 23; 283(21):14674-84.J Biol Chem2008-03-24T00:00:002008Activation of Syk by protein kinase C-delta regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via tyrosine phosphorylation of RelA/p65.BrettStevensBrett Michael Stevens39.73010690000000-104.937882000000007596Stevens, BrettAssoc Professor-ResearchD016328Chemicals & DrugsPhysiology2596760.732564NF-kappa BD018799Chemicals & Drugs801770.922348Intercellular Adhesion Molecule-112700 East 19th Avenue2RC2Research 212700 East 19th AvenueAurora80045-2560COD042783Anatomy2837490.653704Endothelial CellsD013917Chemicals & Drugs581400.910846ThrombinREN GENERAL OPERATIONSD051745Chemicals & Drugs28690.931763Protein Kinase C-deltaIntegrative PhysiologySOM-MEDSOM-PEDSSOM-SRGHematologyOncCT ClinicalHematologyBoneMarrow TransplantUniversity of Colorado BoulderUniversity of Colorado Denver - Anschutz Medical CampusSallyStablerSally P Stabler39.74515960000000-104.840628000000001240Stabler, SallyProfessorJonathanGutmanJonathan A Gutman39.74273230000000-104.839191400000001728Gutman, JonathanProfessorDanielPollyeaDaniel Aaron Pollyea39.74273230000000-104.839191400000004039Pollyea, DanielProfessorXianzhongMengXianzhong Meng39.74515960000000-104.84062800000000455Meng, XianzhongProfessorCraigJordanCraig T. Jordan39.74515960000000-104.840628000000007322Jordan, CraigProfessorDouglasSealsDouglas R Seals40.00943840000000-105.27038960000000839Seals, DouglasDistinguished Professor0.8716060.00800096104research areas0.5211380.053482910coauthor of11.58421.3316460similar to1111selected publicationsClaytonSmithClayton A Smith39.74515960000000-104.840628000000005704Smith, ClaytonProfessor-ClinicalKathrynHassellKathryn L Hassell39.74515960000000-104.84062800000000794Hassell, KathrynProfessorAuthorship 2500981034610123Cherry EM, Abbott D, Amaya M, McMahon C, Schwartz M, Rosser J, Sato A, Schowinsky J, Inguva A, Minhajuddin M, Pei S, Stevens B, Winters A, Jordan CT, Smith C, Gutman JA, Pollyea DABlood advancesCherry EM, Abbott D, Amaya M, McMahon C, Schwartz M, Rosser J, Sato A, Schowinsky J, Inguva A, Minhajuddin M, Pei S, Stevens B, Winters A, Jordan CT, Smith C, Gutman JA, Pollyea DA. Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia. Blood Adv. 2021 12 28; 5(24):5565-5573.Blood Adv2021-12-28T00:00:002021Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia.Authorship 214001Authorship 265833435902048Winters AC, Bosma G, Abbott D, Minhajuddin M, Jordan C, Pollyea DA, Gutman JATransplantation and cellular therapyWinters AC, Bosma G, Abbott D, Minhajuddin M, Jordan C, Pollyea DA, Gutman JA. Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax?+?Azacitidine Versus Intensive Chemotherapy. Transplant Cell Ther. 2022 10; 28(10):694.e1-694.e9.Transplant Cell Ther2022-07-25T00:00:002022Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax?+?Azacitidine Versus Intensive Chemotherapy.Authorship 239533Authorship 253001true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assoc Professor-ResearchAssoc Professor-Researchtrue1Asst ProfessorAsst Professortrue1ProfessorProfessortrue1Professor-ClinicalProfessor-Clinicaltrue1ProfessorProfessortrue1Assoc Professor-ResearchAssoc Professor-Researchtrue1AffiliateAffiliateAuthorship 296856238105738Winters AC, Minhajuddin M, Stevens BM, Major A, Bosma G, Abbott D, Miltgen N, Yuan J, Treece AL, Siegele BJ, Ewalt MD, Gutman JA, Jordan CT, Pollyea DAHaematologicaWinters AC, Minhajuddin M, Stevens BM, Major A, Bosma G, Abbott D, Miltgen N, Yuan J, Treece AL, Siegele BJ, Ewalt MD, Gutman JA, Jordan CT, Pollyea DA. Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine. Haematologica. 2023 Dec 14.Haematologica2023-12-14T00:00:002023Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine.true1Distinguished ProfessorDistinguished ProfessorAuthorship 441293AnnaJovanovichAnna J. Jovanovich39.74515960000000-104.840628000000008779Jovanovich, AnnaAffiliateAuthorship 63174224577530Callahan KP, Minhajuddin M, Corbett C, Lagadinou ED, Rossi RM, Grose V, Balys MM, Pan L, Jacob S, Frontier A, Grever MR, Lucas DM, Kinghorn AD, Liesveld JL, Becker MW, Jordan CTLeukemiaCallahan KP, Minhajuddin M, Corbett C, Lagadinou ED, Rossi RM, Grose V, Balys MM, Pan L, Jacob S, Frontier A, Grever MR, Lucas DM, Kinghorn AD, Liesveld JL, Becker MW, Jordan CT. Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity. Leukemia. 2014 Oct; 28(10):1960-8.Leukemia2014-02-28T00:00:002014Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity.Authorship 1165752Authorship 755722